Table 1

Clinical characteristics of 28 primary ovarian cancers

Case no.PathologyStageaResponseb
108SerousIIICCR
133SerousIIICCR
141SerousIIICCR
159SerousIIICCR
160SerousIIICCR
111SerousIVCR
128MucinousIICCR
161MucinousIIIACR
163EndometrioidIICCR
150EndometrioidIIIBCR
104EndometrioidIIICCR
148EndometrioidIIICCR
171Clear cellIICCR
173Clear cellIICCR
112SerousIIICPD
164SerousIIICPD
166SerousIIICPD
172SerousIIICPD
119SerousIVPD
158MucinousIIICPD
145MucinousIVPD
134EndometrioidICPD
101Clear cellIVPD
165Clear cellIIIBPD
109Clear cellIIICPD
132Clear cellIIICPD
152Clear cellIIICPD
167Clear cellIIICPD
  • a FIGO clinical stage.

  • b Response to cisplatin-based chemotherapy, represented by either CR or PD, according to the criteria proposed by the Japanese Association for Cancer Treatment.